Human infections due to Mycobacterium lentiflavum: first report in Iran
-
M Shamaei
,
M Marjani
,
P Farnia
,
P Tabarsi
,
D Mansouri
Abstract
Non-tuberculosis mycobacteria (NTM), as certain species of mycobacteria, can affect human in several ways. In the preceding years, the rate of NTM detection has risen in both immunocompromised and immunocompetent patients. On the other hand, several reports have debated the possibility of co-infection of both Mycobcateriu tuberculosis (MTB) and NTM in individuals that puts the role of NTM in disease manifestations under question. Moreover, it is now proven that some of the cases that are identified as anti-TB treatment failure or suspected for drug resistance are actually NTM.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculosis Mycobaterial Diseases. Am J Respir Crit Care Med 2003; 175: 367-416.
McNabb AD, Eisler K , Adile M , Amos M , Rodri- gues G, Stephens WA , Black I , Renton J. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65)for routine identification of my- cobacterium species isolated from clinical sources. J Clin Microbiol 2004; 42: 3000-3011.
Tortoli E. Impact of genotypic studies on mycobacte- rial taxonomy: the new mycobacteria of the 1990’s. Clin Microbiol Rev 2003; 2: 319-354.
World Health organization. Guidelines for the program- matic management of drug resistance tuberculosis. WHO/ HTM / TB/ 2006. 361. Geneva, Switzerland: WHO 2006.
Matos ED, Santana MA, de Santana MC, Mamede P, de Lira Bezerra B, Panao ED, et al. Nontuberculosis My- cobacteria at a Multi-resistant Tuberculosis Reference Center in Bahia: Clinical Epidemiological Aspects. Braz J Infect Dis 2004 Aug; 8 (4): 296-304.
Kim SJ. Drug – susceptibility testing in tuberculosis:methods and reliability of results. European Respire J.2005; 25: 564-569.
Lind A, Larsson LO, Bentzon MW, Magnusson M, Olofson J, Sjögren I, et al. Sensitivity to sensitins and tuberculin in Swedish children. I. A study of school chil- dren in an urban area.Tubercle 1991; 72: 29-36.
Reznikov M, Robinson E. Serologically identical Battey mycobacteria from sputa of healthy piggery workers and lesions of pigs. Aust Vet J 1970; 46:606-607.
Springer B, Wu WK, Bodmer T, Hasse G, Pfyffer GE, Kroppenstedt RM, et al. Isolation and Char- acterization of a unique group of slowly growing mycobacteria:description of Mycobacterium lentifla- vum sp.nov. J Clin Microbiol 1996: 34: 1100-1107.
Haase G, Kentrup H, Skopnik H, Springer B, Bottger EC. Mycobacterium lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis 1997; 25: 1245-6.
Tortoli E, Mattei R, Russo C, Scarparo C. Mycobacte- rium Lentiflavum an emerging pathogen? J Infect 2005;52: 185-187.
Safdar A, Han XY. Mycobacterium lentiflavum, a re- cently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer pa- tients and summary of reported cases of infection. Eur J Clin Microbiol Infect Dis 2005; 24: 554-558.
Holt JG, Krieg NR, Sneath PHA, Staley JT, William ST, editors. Bergey’s manual of systemic bacteriology Bal- timore: Williams & Wilkins. 1994, 597P.
Kent PT, Kubica GP, Public health Mycobacteriol- ogy: A guide for the level III laboratory, Department of Health and Human Services, Centers for Diseases Con- trol, Atlanta, Ga. 1985:P-36-138.
Molteni C, Gazzola L, Cesari M, Lombardi A, Salerno F, Tortoli E, et al. Mycobacterium lentiflavum infection in immunocompetent patient. Emerg Infect Dis 2005;11:119-122.
| Files | ||
| Issue | Vol 2 No 1 (2010) | |
| Section | Articles | |
| Keywords | ||
| Mycobacterium lentiflavum NTM Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
